United States Colorectal Cancer Drugs Market Poised for Strong Growth as Innovative Therapies Transform Global Treatment Landscape 2025 | Major key players - AstraZeneca, Roche, Merck & Co.

Market Size and Growth:

The Global Colorectal Cancer Drugs Market size is projected to grow from US$ 12.60 billion in 2024 to US$ 19.96 billion by 2033, registering a CAGR of 5.2% during the forecast period 2025-2033.

The Colorectal Cancer Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/colorectal-cancer-drugs-market?sz

The Colorectal Cancer Drugs Market refers to the global industry focused on the development, production, and commercialization of therapies used for the prevention, treatment, and management of colorectal cancer. It includes chemotherapy, targeted therapy, immunotherapy, and combination treatments, driven by rising cancer prevalence, advancements in oncology research, and increasing demand for effective, personalized treatment options worldwide.

Recent Key Developments of United States (U.S):

September 2025: The FDA approved an investigational new drug application for ABT-301, allowing for a Phase 1/2 clinical trial in combination with Tevimbra and Avastin for treating metastatic colorectal cancer.

August 2025: A companion diagnostic test, the mismatch repair immunohistochemical panel pharmDx, was approved by the FDA. This test helps identify patients with mismatch repair deficient colorectal cancer who may be eligible for treatment with Opdivo (nivolumab) alone or in combination with Yervoy (ipilimumab).

July 2025: PDS Biotechnology Corporation completed patient recruitment for Stage 1 of a clinical trial for metastatic colorectal cancer patients using the PDS01ADC therapeutic, in combination with floxuridine.

June 2025: The FDA approved the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) as a first-line treatment for patients with previously untreated microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) unresectable or metastatic colorectal cancer.

June 2025: Enzene Biosciences launched Bevacizumab, a biosimilar drug for metastatic colorectal cancer, as a more affordable alternative to Avastin.

List of the Key Players in the Colorectal Cancer Drugs Market:

Roche
Merck & Co., Inc.
Bristol-Myers Squibb
Amgen
Pfizer
Eli Lilly and Company
Bayer
Taiho Oncology.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=colorectal-cancer-drugs-market

Segments Covered in the Colorectal Cancer Drugs Market:

By Drug Class: Chemotherapy, Targeted Therapy, Immunotherapy.

By Route of Administration: Intravenous, Oral.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/colorectal-cancer-drugs-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Colorectal Cancer Drugs market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Colorectal Cancer Drugs Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Colorectal Cancer Drugs market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Colorectal Cancer Drugs Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Colorectal Cancer Drugs Market in 2025?
◆ What is the projected growth rate of the Colorectal Cancer Drugs Market through 2033?
◆ Who are the key players in the Colorectal Cancer Drugs Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.